Perú Sessions: Young Interventionists Clinical Case Contest

“Fostering Hemodynamics among Young Cardiologists”.

It is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Lima, Perú, to be held on October 25th and 2nd, 2018.

HOW TO PRESENT A CASE

    • Case submission is meant for young Latin American interventional cardiologists and topics include: adult peripheral vascular and structural heart interventional cardiology.
    • In each case, only one interventionist can sign up. Being a fellow cardiologist or interventionist is not required.
    • Attach a letter of recommendation from the Chief of the Hemodynamic Service you belong to.
    • Send a Word file with your case description, no longer than 300 words, font size 11.
    • Send a complementary Power Point file with your case presentation. Even though you may use videos (up to 5) for your oral presentation during our sessions (up to 5), this initial file may only include up to 5 pictures only.
    • One cardiologist may present more than one case. If such were the case, they should be sent separately.
    • Include personal information: name and last name, phone number, email address, case title and institution you are working for. 

WHERE TO SUBMIT A CASE

Cases must be submitted through the following form

If you have problems with the form, send your case directly to webservices@solaci.org and jornadas@solaci.org, complying with the requirements requested here (summary of the case in word, file of the case in PPT, endorsement letter, personal data, etc.”

 

DEADLINE

Tuesday, September 25th, 2018.

 

EVALUATION PROCESS

All cases will be initially evaluated by the appointed committee and shortlisted to the best 8, which shall be presented orally during our sessions. During these presentations, a second complementary evaluation will decide on the winner.

PRIZE

The winner shall obtain a full scholarship to attend one of the upcoming SOLACI Sessions, including plane tickets, lodging, and registration fees for such event.

If you have questions or concerns, write to Jornadas@solaci.org.

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...